SCHEMBL6276094

SCHEMBL6276094

CCCCOc1c(O)c2cc(OCC(=O)O)ccc2oc1=O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 6/20 0.55
▸ ALDH1A1 P00352 6/20 0.55
▸ HPGD P15428 4/20 0.55
▸ LMNA P02545 1/20 0.52
▸ LOXL2 Q9Y4K0 1/20 0.49
▸ AKR1C3 P42330 1/20 0.49
▸ AKR1C2 P52895 1/20 0.49
▸ AKR1C1 Q04828 1/20 0.49
▸ NPC1 O15118 2/20 0.47
▸ RAB9A P51151 2/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.47
▸ MAPT P10636 1/20 0.46
▸ TSHR P16473 2/20 0.46
▸ PLA2G4B P0C869 1/20 0.46
▸ NQO1 P15559 1/20 0.45
▸ PTPN1 P18031 1/20 0.44
▸ HSD17B10 Q99714 2/20 0.44
▸ GAA P10253 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ ACSL1 P33121 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6276878 0.98 KDM4E (0.53) KDM4EALDH1A1HPGDLMNALOXL2
SCHEMBL6270329 0.97 KDM4E (0.52) KDM4EALDH1A1HPGDLMNALOXL2
SCHEMBL6276647 0.97 KDM4E (0.52) KDM4EALDH1A1HPGDLMNALOXL2
SCHEMBL6275937 0.97 KDM4E (0.52) KDM4EALDH1A1HPGDLMNALOXL2
SCHEMBL6272551 0.97 KDM4E (0.52) KDM4EALDH1A1HPGDLMNALOXL2
SCHEMBL6276175 0.95 KDM4E (0.55) KDM4EALDH1A1HPGDLMNALOXL2
SCHEMBL6275581 0.91 AKR1C3 (0.58) KDM4EALDH1A1HPGDAKR1C3AKR1C2
SCHEMBL6273079 0.91 KDM4E (0.57) KDM4EALDH1A1HPGDLMNALOXL2
SCHEMBL6277212 0.90 ACSL1 (0.53) KDM4EALDH1A1HPGDRAB9ASMN1; SMN2
SCHEMBL6274684 0.90 ACSL1 (0.50) KDM4EALDH1A1HPGDLMNANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1273578-B1 Benzopyran derivatives and antiallergic agent containing the same DAINIPPON INK & CHEMICALS (JP) 2005-02-23 — — EP disclosed
US-6670391-B2 For inhibiting both immediate and delayed type allergic reactions; side effect reduction DAINIPPON INK AND CHEMICALS, INC. (JP) 2003-12-30 — — US disclosed
US-20030096860-A1 Benzopyran derivative and antiallergic agent DAINIPPON INK AND CHEMICALS, INC. (JP) 2003-05-22 — — US disclosed
EP-1273578-A1 Benzopyran derivatives and antiallergic agent containing the same DAINIPPON INK AND CHEMICALS, INC. (JP) 2003-01-08 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030096860-A1 Benzopyran derivative and antiallergic agent HRH2, HRH1, HRH4 KDM4E 965/4885ALDH1A1 105/4885HPGD 324/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback